Detalhe da pesquisa
1.
Multi-omics and imaging mass cytometry characterization of human kidneys to identify pathways and phenotypes associated with impaired kidney function.
Kidney Int
; 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38431215
2.
scRNA Transcription Profile of Adult Zebrafish Podocytes Using a Novel Reporter Strain.
Cell Physiol Biochem
; 55(S4): 35-47, 2021 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33945241
3.
Investigating the RAS can be a fishy business: interdisciplinary opportunities using Zebrafish.
Clin Sci (Lond)
; 132(23): 2469-2481, 2018 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30518571
4.
Copper Catalysis in Living Systems and Inâ Situ Drug Synthesis.
Angew Chem Int Ed Engl
; 55(50): 15662-15666, 2016 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27860120
5.
The ATR inhibitor ceralasertib potentiates cancer checkpoint immunotherapy by regulating the tumor microenvironment.
Nat Commun
; 15(1): 1700, 2024 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38402224
6.
Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models.
NPJ Breast Cancer
; 9(1): 64, 2023 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37543694
7.
Comparative Studies of Renin-Null Zebrafish and Mice Provide New Functional Insights.
Hypertension
; 79(3): e56-e66, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35000430
8.
Holistic Characterization of a Salmonella Typhimurium Infection Model Using Integrated Molecular Imaging.
J Am Soc Mass Spectrom
; 32(12): 2791-2802, 2021 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34767352
9.
Author Correction: Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models.
NPJ Breast Cancer
; 9(1): 76, 2023 Sep 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37726304
10.
Author Correction: Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models.
NPJ Breast Cancer
; 9(1): 69, 2023 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37596288